IL66227A - N-(2-(5-dimethylaminomethyl-furan-2-yl-methylthio)-ethyl)-benzamide derivatives and their salts,their preparation and pharmaceutical compositions containing them - Google Patents

N-(2-(5-dimethylaminomethyl-furan-2-yl-methylthio)-ethyl)-benzamide derivatives and their salts,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL66227A
IL66227A IL66227A IL6622782A IL66227A IL 66227 A IL66227 A IL 66227A IL 66227 A IL66227 A IL 66227A IL 6622782 A IL6622782 A IL 6622782A IL 66227 A IL66227 A IL 66227A
Authority
IL
Israel
Prior art keywords
dimethylaminomethyl
methylthio
furan
salts
ethyl
Prior art date
Application number
IL66227A
Other languages
English (en)
Other versions
IL66227A0 (en
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8113420A external-priority patent/FR2509305B1/fr
Priority claimed from FR8119967A external-priority patent/FR2515181A1/fr
Priority claimed from FR8123084A external-priority patent/FR2518097A1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IL66227A0 publication Critical patent/IL66227A0/xx
Publication of IL66227A publication Critical patent/IL66227A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL66227A 1981-07-08 1982-07-05 N-(2-(5-dimethylaminomethyl-furan-2-yl-methylthio)-ethyl)-benzamide derivatives and their salts,their preparation and pharmaceutical compositions containing them IL66227A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8113420A FR2509305B1 (fr) 1981-07-08 1981-07-08 Benzamides, procede pour leur preparation et compositions pharmaceutiques les renfermant
FR8119967A FR2515181A1 (fr) 1981-10-23 1981-10-23 Amidobenzamides, procede pour leur preparation et compositions pharmaceutiques les renfermant
FR8123084A FR2518097A1 (fr) 1981-12-10 1981-12-10 Amidobenzamide, procede pour sa preparation et compositions pharmaceutiques la renfermant

Publications (2)

Publication Number Publication Date
IL66227A0 IL66227A0 (en) 1982-11-30
IL66227A true IL66227A (en) 1985-07-31

Family

ID=27251063

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66227A IL66227A (en) 1981-07-08 1982-07-05 N-(2-(5-dimethylaminomethyl-furan-2-yl-methylthio)-ethyl)-benzamide derivatives and their salts,their preparation and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US4439444A (de)
EP (1) EP0069664B1 (de)
AR (1) AR231288A1 (de)
AU (1) AU547405B2 (de)
CA (1) CA1190927A (de)
DD (1) DD202433A5 (de)
DE (1) DE3262870D1 (de)
DK (1) DK305982A (de)
ES (1) ES513792A0 (de)
FI (1) FI822408L (de)
GR (1) GR76007B (de)
HU (1) HU189599B (de)
IL (1) IL66227A (de)
NO (1) NO822122L (de)
NZ (1) NZ201197A (de)
PT (1) PT75209B (de)
YU (1) YU149482A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531706A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
GB8422461D0 (en) * 1984-09-05 1984-10-10 Wyeth John & Brother Ltd Pyridine derivatives
US4912101A (en) * 1987-03-13 1990-03-27 Fujirebio Kabushiki Kaisha 4-aminomethyl-pyridyl-2-oxy derivatives having anti-ulcer activity
GB8921792D0 (en) * 1989-09-27 1989-11-08 May & Baker Ltd New compositions of matter
WO1994012473A1 (en) * 1992-11-20 1994-06-09 Kaken Pharmaceutical Co., Ltd. Acetamide derivative
MY153898A (en) * 2005-06-22 2015-04-15 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
CA2738573C (en) 2009-04-03 2013-02-19 F. Hoffmann-La Roche Ag Compositions of propane-1 sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide and uses thereof
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
JP2013510166A (ja) 2009-11-06 2013-03-21 プレキシコン インコーポレーテッド キナーゼ調節のための化合物、方法およびその適用
PE20141360A1 (es) 2011-02-07 2014-10-13 Plexxikon Inc Compuestos y metodos para la modulacion de quinasas e indicaciones para los mismos.
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
JPS5681578A (en) * 1979-12-07 1981-07-03 Shionogi & Co Ltd Novel thioalkyl amide derivative

Also Published As

Publication number Publication date
IL66227A0 (en) 1982-11-30
AU547405B2 (en) 1985-10-17
FI822408A7 (fi) 1983-01-09
PT75209B (fr) 1984-06-27
NZ201197A (en) 1985-01-31
ES8308326A1 (es) 1983-08-16
PT75209A (fr) 1982-08-01
FI822408A0 (fi) 1982-07-07
YU149482A (en) 1984-12-31
DK305982A (da) 1983-01-09
EP0069664B1 (de) 1985-04-03
FI822408L (fi) 1983-01-09
NO822122L (no) 1983-01-10
GR76007B (de) 1984-08-03
US4439444A (en) 1984-03-27
AU8513482A (en) 1983-01-13
HU189599B (en) 1986-07-28
EP0069664A1 (de) 1983-01-12
ES513792A0 (es) 1983-08-16
DE3262870D1 (en) 1985-05-09
AR231288A1 (es) 1984-10-31
DD202433A5 (de) 1983-09-14
CA1190927A (en) 1985-07-23

Similar Documents

Publication Publication Date Title
IL65963A0 (en) Bis-triazole derivative and salts thereof,their preparation and pharmaceutical compositions containing them
IL82265A (en) N-(2'-aminophenyl)-benzamide derivatives,their preparation and pharmaceutical compositions containing them
IL73125A0 (en) 1-benzyl-aminoalkyl-pyrrolidinones and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
IL75038A (en) 2-(n-substituted guanidino)-4-heteroarylthiazoles and pharmaceutical compositions containing them
IL87080A (en) 4-amino-5-halo 2,n-disubstituted benzamides,their preparation and pharmaceutical compositions containing them
EP0193415A3 (en) Spiro-3-heteroazolidine compounds and salts thereof, their preparation and pharmaceutical agents thereof
IL65097A0 (en) N-(4-(indolyl)-piperidino-alkyl)-benzimidazolones,their preparation and pharmaceutical compositions containing them
IL80339A (en) 2-(2-(2-pyridyl)- phenylsulphinyl) -benzimidazoles, their preparation and pharmaceutical compositions containing them
EP0033655A3 (en) Imidazoline derivative, its salts, process for preparation, pharmaceutical compositions and therapeutic use, thereof
IL66227A0 (en) Amidobenzamides and their salts,their preparation and pharmaceutical compositions containing them
IL66870A0 (en) 2-phenyl-2-(pyridyloxy)-ethylamine derivatives,their preparation and pharmaceutical compositions containing them
IL68710A0 (en) 2-(1h)-pyridinone derivatives,their preparation and pharmaceutical compositions containing them
IL68872A0 (en) N-(2-methoxyethyl)-noroxymorphone and salts thereof,their preparation and pharmaceutical compositions containing them
GB2106115B (en) Pharmaceutical amides, and preparation, formulations and use thereof
IL66433A (en) Spirothiazolidinyl piperazine derivatives,their preparation and pharmaceutical compositions containing them
IL65169A0 (en) Substituted trifluoromethylphenyltetrahydropyridines and salts thereof,their preparation and pharmaceutical compositions containing them
IL76166A0 (en) Cyclimmonium salts,their preparation and pharmaceutical compositions containing them
IL73205A0 (en) Substituted benzamide derivatives,their preparation and pharmaceutical compositions containing them
IL58379A (en) N-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulphamoyl benzamide,its oxide and salts,their preparation and pharmaceutical compositions containing them
IL65416A (en) 3-(2-(tetra-and hexa-hydro-4-pyridyl)-ethyl)-indoles,their preparation and pharmaceutical compositions containing them
IL65876A0 (en) Heterocyclic amidoxime derivatives,their preparation and pharmaceutical compositions containing them
IL63217A (en) N-(1-allyl-2-pyrrolidinyl-methyl)2-methoxy-4-amino-5-methylsulfamoyl benzamide,its preparation and pharmaceutical compositions containing it
IL73832A0 (en) 2-(1-imidazolyl)-ethanol derivatives,their preparation and pharmaceutical compositions containing them
IL79241A (en) N-((2-imidazolin-2-yl)alkyl)-4-amino-5-halo benzamide derivatives,their preparation and pharmaceutical compositions containing them
IL70273A (en) N-(substituted alkyl)acridanone-2-thiazole-2-yl-hydrazone derivatives,their manufacture and pharmaceutical compositions containing them